Paris, October 9, 2024. Sanofi advances its ambition to protect all infants from respiratory syncytial virus (RSV) disease with new Beyfortus (nirsevimab) data to be presented at the Infectious ...

Sanofi to present data from Beyfortus to treat RSV diseases at IDWeek 2024 annual meeting: Paris Thursday, October 10, 2024, 12:00 Hrs [IST] Sanofi advances its ambition to protec ...

Pfizer to present data across respiratory and other infectious diseases portfolio at IDWeek 2024 congress: New York Thursday, October 10, 2024, 09:00 Hrs [IST] Pfizer Inc. will pr ...

Presentations highlight momentum of Pfizer's portfolio of infectious disease prevention and treatment options NEW YORK, October 8, 2024 - Pfizer Inc ...

IDWeek is the joint annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, the Pediatric Infectious Diseases ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of new findings from its antiviral research ...

New Data to be Presented at IDWeek 2024 Reinforce Merck’s Broad and Diverse Vaccines and Infectious Disease Pipeline and ...

New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infantsParis, October 9, ...

Our college football experts predict, pick and preview the New Mexico State Aggies vs. Jacksonville State Gamecocks game, ...

(NYSE: PFE) will present data across its infectious disease portfolio at the upcoming IDWeek 2024 congress, held in Los Angeles ...

ActivePure Medical, a division of AP Sciences Group, LLC, a global provider of cutting-edge, continuous air and surface decontamination technology for healthcare, today announced it will present two ...